Next Article in Journal
Growth Factor Mediated Signaling in Pancreatic Pathogenesis
Next Article in Special Issue
Gold Nanostructures as a Platform for Combinational Therapy in Future Cancer Therapeutics
Previous Article in Journal
Mastic Oil Inhibits the Metastatic Phenotype of Mouse Lung Adenocarcinoma Cells
Previous Article in Special Issue
Progress in Nanotechnology Based Approaches to Enhance the Potential of Chemopreventive Agents
Cancers 2011, 3(1), 802-840; doi:10.3390/cancers3010802
Article

Plasmonic Nanobubbles as Tunable Cellular Probes for Cancer Theranostics

Received: 19 January 2011; in revised form: 12 February 2011 / Accepted: 17 February 2011 / Published: 23 February 2011
(This article belongs to the Special Issue Nanotechnology and Cancer Therapeutics)
View Full-Text   |   Download PDF [1984 KB, uploaded 23 February 2011]   |   Browse Figures
Abstract: This review is focused on a novel cellular probe, the plasmonic nanobubble (PNB), which has the dynamically tunable and multiple functions of imaging, diagnosis, delivery, therapy and, ultimately, theranostics. The concept of theranostics was recently introduced in order to unite the clinically important stages of treatment, namely diagnosis, therapy and therapy guidance, into one single, rapid and highly accurate procedure. Cell level theranostics will have far-reaching implications for the treatment of cancer and other diseases at their earliest stages. PNBs were developed to support cell level theranostics as a new generation of on-demand tunable cellular probes. A PNB is a transient vapor nanobubble that is generated within nanoseconds around an overheated plasmonic nanoparticle with a short laser pulse. In the short term, we expect that PNB technology will be rapidly adaptable to clinical medicine, where the single cell resolution it provides will be critical for diagnosing incipient or residual disease and eliminating cancer cells, while leaving healthy cells intact. This review discusses mechanisms of plasmonic nanobubbles and their biomedical applications with the focus on cancer cell theranostics.
Keywords: gold nanoparticle; laser; plasmonic nanobubble; theranostics gold nanoparticle; laser; plasmonic nanobubble; theranostics
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Lapotko, D. Plasmonic Nanobubbles as Tunable Cellular Probes for Cancer Theranostics. Cancers 2011, 3, 802-840.

AMA Style

Lapotko D. Plasmonic Nanobubbles as Tunable Cellular Probes for Cancer Theranostics. Cancers. 2011; 3(1):802-840.

Chicago/Turabian Style

Lapotko, Dmitri. 2011. "Plasmonic Nanobubbles as Tunable Cellular Probes for Cancer Theranostics." Cancers 3, no. 1: 802-840.


Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert